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General Introduction 
 
 Vertebrates have the ability to survive food deprivation by maintaining their energy 
metabolism. They can basically use carbohydrates, proteins, and lipids as energy sources. Because lipids 
contain more energy per gram than proteins and carbohydrates (van Dam and Seidell, 2007), they 
function principally as energy reserve. Vertebrates usually store lipids in adipose tissues that are 
distributed in several regions such as visceral, subcutaneous, and intramuscular region (Goodpaster and 
Wolf, 2004). In the case of fish, excess energy intake results in lipid deposition in specific tissues, such as 
adipose tissue, liver, and skeletal muscle (Sheridan, 1988). The distribution patterns of lipids among these 
organs are known to be species-specific. Torafugu (Japanese pufferfish) Takifugu rubripes accumulates 
lipids mainly in the liver but hardly in the skeletal muscle like Japanese flounder Paralichtyhs olivaseus 
and cod Gadus morhua (Ando et al., 1993; Santos et al., 1993). These fish, often referred to as “lean fish”, 
usually have no mature adipose tissue. On the other hand, “fatty fish” species including red seabream 
Pagrus major, amberjack Seriola dumerili, and Japanese eel Anguilla japonica accumulates lipids in liver, 
skeletal muscle, and adipose tissues (Ando et al., 1993; Oku et al., 2009). Since the lipid contents of fish 
body affect its taste and the quality of final products, most previous studies on fish lipid metabolism have 
been conducted on the latter group. However, cross-species comparison between lean and fatty fish may 
also provide us with information about the similarities and differences of the process. It will enable us to 
understand more basic aspects of fish lipid metabolism. For these reasons, this study focused on the 
mechanisms of maintaining lipid metabolism in lean fish. 
 
Stored lipid metabolism in fish 
 The excess energy obtained by feeding is stored in the form of triacylglycerols (TAGs) in 
several tissues. TAG is a neural lipid consisting of a glycerol backbone bonded to three fatty acids 
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esterified, which are provided from blood circulation or synthesized de novo catalyzed by fatty acid 
synthase (FAS) (Tocher, 2003). When the energy demands are increased due to the fasting or exercise, 
stored TAGs are hydrolyzed by hormone sensitive lipase (HSL) to release free fatty acids (non-esterified 
fatty acids, NEFAs) as energy fuels (Nakamura et al., 2014). These resulting NEFAs are subsequently 
esterified to coenzyme A (CoA) to form fatty acyl-CoA, and transported into mitochondria to undergo 
β-oxidation. Carnitine palmitoyltransferase 1 (CPT1), localized on the mitochondrial outer membrane, is 
known as the rate-limiting enzyme of β-oxidation catalyzing fatty acyl-CoA transport into the 
mitochondrial matrix (Kerner and Hoppel, 2000). The fatty acyl chains derived from NEFAs are then 
oxidized to produce acetyl-CoA, the substrate of tricarboxylic acid (TCA) cycle for energy production. 
These enzymes, which play important roles in lipid metabolism, are identified in fish species with similar 
forms and functions as in mammals, suggesting the conservation of lipid metabolism among vertebrates. 
Because of the hydrophobic nature of TAG, it forms lipid droplets for long-term storage. The 
distribution pattern of lipid droplets is tissue-specific in fish. In liver and adipose tissue, numerous lipid 
droplets are observed in cytoplasm of hepatocytes and adipocytes, respectively (Akiyoshi and Inoue, 
2004; Oku and Umino, 2008), whereas in skeletal muscle, the adipocyte-like cells including abundant 
lipid droplets are localized along the myosepta (Tocher, 2003; Kaneko et al., 2013). 
  
Circulation of lipids and lipoproteins 
 Body lipid mobilization is induced depending on the energy demand of peripheral tissues. 
Since TAGs, the typical lipids stored in tissues, are insoluble in water, they associate with apolipoproteins 
to form lipoprotein complexes (Murray et al., 2003). As in mammals, fish lipoproteins are classified into 
chylomicron (CM), very low-density lipoproteins (VLDLs), low-density lipoproteins (LDLs), and 
high-density lipoproteins (HDLs) depending on the densities and particle sizes (Chapman et al., 1978; 
Babin and Vernier, 1989; Iijima et al., 1995). CM is a dietary-derived triacylglycerol (TAG)-rich 
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lipoprotein produced from intestine in the postprandial period. VLDL is a secondly TAG-rich lipoprotein 
released from liver, which has the function of TAG transport from liver to peripheral tissues. TAGs in 
these lipoproteins are incorporated into peripheral tissues by mainly two ways. One is enzyme-mediated 
incorporation. TAGs in lipoproteins are hydrolyzed by lipoprotein lipase (LPL), an enzyme localized on 
the surface of endothelial cells of many tissues, into NEFAs and 2-monoacylglycerols during circulation 
(Kurtovic et al., 2009). The resulting NEFAs are absorbed into each tissue via CD36, a fatty acid 
transporter (Abumrad et al., 1993), and used for β-oxidation or stored again as TAG after re-esterification. 
The remnant of the hydrolyzed VLDL is presumably formed into LDL (Sheridan, 1988). HDL is also the 
product from VLDL digested by LPL as revealed in isolated hepatocytes of Japanese eel (Yu et al., 1992). 
LDL and HDL mainly transport cholesterol and are eventually absorbed by liver and peripheral tissues 
via receptor-mediated endocytosis. The other way of TAG-rich lipoprotein incorporation is 
receptor-mediated endocytosis of plasma lipoproteins (Sakai et al., 1994). In mammalian studies, VLDL 
receptor is revealed to be involved in the CM and VLDL clearance in postprandial period (Goudriaan et 
al., 2004). Although there are few studies about lipoprotein receptors in fish, a previous study showed that 
the high fat line of rainbow trout has higher mRNA levels of VLDL receptor in its muscle (Kolditz et al., 
2010), suggesting its contribution to lipids uptake into fish muscle. 
 
Torafugu, a typical lean fish species 
 The total lipid contents of skeletal muscles in fatty fish vary depending on the dietary lipid 
level (Gélineau et al., 2001; Han et al., 2011; Lu et al., 2013). On the other hand, those in lean fish such 
as haddock Melanogrammus aeglefinus L., flounder, and torafugu showed constant levels irrespective of 
the dietary lipid level (Nanton et al., 2001; Lee and Kim, 2005; Kikuchi et al., 2009). Especially, torafugu 
marginally accumulates lipid in its skeletal muscle (approximately 1%), which does not show any 
changes depending on the seasons or nutritional conditions (Koizumi and Hiratsuka, 2009); meanwhile, 
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substantial lipids are deposited in its liver (approximately 65%). A previous study revealed that the gene 
expression level of LPL, an enzyme responsible for lipid uptake as described before, is significantly low 
in torafugu muscle compared to that in its liver (Kaneko et al., 2013). These reports suggest that the lipid 
accumulation in muscle is somehow repressed in torafugu and thus its liver would play an important role 
for maintaining lipid metabolism in torafugu whole body. Torafugu has the smallest genome among 
vertebrates and its whole-genome database is available (Aparicio et al., 2002), making it easy to 
undertake the experiments using gene information. Therefore, in this study, torafugu is chosen as a model 
lean fish species. 
 
Growth hormone signaling in fish 
Growth hormone (GH) is a peptide hormone produced and released from the pituitary gland 
and other sites in vertebrates. This hormone has pluripotent functions in regulating growth, 
osmoregulation, immunity, and energy metabolism. Especially, GH-transgenic and GH-treated fish show 
enhanced somatic growth (Fuentes et al., 2013), indicating that GH has significant effects in improving 
the growth rate of fish. To take advantage of the valuable effect of this hormone to aquaculture industry, 
it is meaningful to increase the knowledge of GH effects on fish metabolism from a broad perspective. 
Many previous studies suggest that GH regulates the lipid metabolism in teleost species. 
GH-transgenic coho salmon Oncorhynchus kisutch has lower lipid content of whole body compared to 
non-transgenic individual (Raven et al., 2006). GH treatment decreases the lipid contents of liver and 
muscle in rainbow trout (Kling et al., 2012). These reports support the idea that fish GH has lipolytic 
effect observed in mammals (Sheridan, 1994). However, almost all studies were performed using fatty 
fish species as mentioned before. The present study therefore investigated the molecular function of GH 
on lipid metabolism in lean fish, torafugu, to understand the overall ability of GH in fish. 
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The specific receptor for GH 
 The GH signaling is transmitted through the specific receptor, GH receptor (GHR), on the cell 
surface of target tissues (Herrington and Carter-Su, 2001). GH binds to GHR and leads its dimerization 
with the conformation change that stimulates the tyrosine kinase activity of GHR. Subsequently, the 
dimerized GHR phosphorylates each other, resulting in the further activation of signaling molecules in 
cytoplasm including transcription factors to regulate target gene expressions. In mammal studies, skeletal 
muscle-specific GHR knockout mice show decreased activation of signaling molecules in skeletal muscle 
with peripheral adiposity (Mavalli et al., 2010). Liver-specific GHR knockout mice also display marked 
steatosis and decreased insulin-like growth factor I (IGF-I) gene expression, a primary target gene of GH 
in liver (Fan et al., 2009; List et al., 2014). Under the fasting condition, rainbow trout show decreased 
mRNA expressions of GHR and IGF-I in liver with reduced GH binding, although the circulating GH 
level is increased compared to those under the fed condition (Norbeck et al., 2007). These reports strongly 
indicate that the abundances of GHR in target tissues determine the GH responsiveness and physiological 
action. 
    
Ex vivo tissue culturing 
 The energy metabolism is maintained in living body by numerous factors, such as endocrine 
and nervous systems. To observe the specific function of GH on each tissue, the effects derived from 
other factors should be eliminated. Ex vivo tissue culturing, keeping the tissue pieces in an artificial 
environment, is the optimal system to study such hormonal function. The results obtained from this 
system can be thought to reflect the behavior in a living body because of the maintained heterogeneous 
cell population of tissues. Many previous studies applied ex vivo system for investigating tissue functions 
in fish (O’ Connor et al., 1993; Frolow and Milligan, 2004; Matsumoto et al., 2005). In this study, GH 
treatment was performed using ex vivo tissue culturing system for liver and muscle in serum-free 
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Leibovitz’s L-15 medium, which is known as amino acid-rich medium and often used for fish cell culture. 
 
Transcriptome analyses 
 With the previous progress of technologies for the gene expression analyses, the number of 
studies applying the transcriptome analyses for investigating fish metabolism has increased (Qian et al., 
2014). As for torafugu studies, both DNA micoarray and RNA-seq technologies are revealed to be 
applicable (Matsumoto et al., 2014; Cui et al., 2014; Feroudj et al., 2014). DNA microarray is a 
hybridization-based technology using fluorescently labeled cDNA and oligonucleotide probes fixed onto 
a solid surface. RNA-seq, on the other hand, is a sequence-based technology determining the transcript 
sequences directly with the next generation sequencer. Both technologies have advantages and 
disadvantages, such as sensitivity, throughput, and cost per sample. In this study, transcriptome analysis 
using microarray was performed for comparing the effect of recombinant hormone to the same population 
of genes. 
 
 Based on these backgrounds, the present study investigated the molecular mechanisms of GH 
to maintain lipid metabolism in torafugu as outlined below. 
In Chapter 1, the effects of torafugu GH on torafugu liver and muscle metabolism were 
investigated using ex vivo system. Torafugu GH cDNA was cloned and its open reading frame sequence 
was inserted into pQE-30 Xa bacterial vector. Using bacterial protein expression system, recombinant 
torafugu GH (rtGH) was produced. Tissue slices from liver and muscle of torafugu were cultured in L15 
medium and treated with rtGH (5 ng/ml) for expected periods of time. Transcriptome analysis with 
oligo-microarray indicated that the effectc of GH on gene regulations were tissue-specific. The activation 
of GH signaling molecules was investigated by Western blot analysis using specific antibodies for signal 
transducer and activator of transcription (STAT), protein kinase B (Akt), and extracellular 
 7 
signal-regulated kinase (ERK) to detect their phosphorylation ratio. As for liver slices, both Akt and ERK 
were significantly activated after 60 min stimulation with rtGH. On the other hand, in muscle slices, all of 
these signaling molecules tested in this study did not alter their activation during 60 min stimulation with 
rtGH. These results suggest that the sensitivity of rtGH signaling is also tissue-specific. Quantitative 
real-time PCR analysis for lipid metabolism related genes revealed that rtGH down-regulated the gene 
expressions of LPL and FAS after 1 and 12 hours of rtGH addition, respectively, and up-regulated those 
of CPT1 after 24 hours of rtGH addition in liver slices. These results indicate that rtGH repress the lipid 
influx and lipogenesis followed by promoting lipid consumption in liver. As for muscle slices, the gene 
expression of FAS was down-regulated after 12 hours of rtGH addition, suggesting the suppression effect 
of de novo fatty acid synthesis in muscle. Overall, these experiments indicate that rtGH has a function for 
regulating lipid metabolism in tissue-dependent manners. 
 In Chapter 2, cDNA cloning of torafugu growth hormone receptor isoforms was performed to 
understanding their molecular characteristics. The full-length cDNAs of two GHR isoforms, GHR1 and 2 
were cloned and identified by phylogenetic analysis. The comparison of the deduced amino acid 
sequences of each GHR isoforms showed that torafugu GHR2 lacked two extracellular cysteine and five 
intracellular tyrosine residues, suggesting that these GHR isoform have different functions in GH/GHR 
signaling. The tissue distributions of the torafugu GHRs were investigated by quantitative real-time PCR 
using gill, heart, skin, fast muscle, slow muscle, liver, and intestine. As a result, all of these tested tissues 
were found to express both torafugu GHRs. The transcript abundance of torafugu GHR1 and GHR2 
tended to be high in fast muscle, slow muscle, and liver. In mammal and other teleost fish, the highest 
relative mRNA levels of GHR have been found in the liver. In torafugu, notably, the significantly highest 
mRNA level of torafugu GHR1 was observed in fast muscle. Taking the results of Chapter 1 into account, 
these GHR distributions imply that the lipogenesis is strongly repressed in torafugu muscle by GH 
signaling. 
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 The TAG distribution among tissues and serum lipoproteins would provide us with the 
information on lipid mobilization capacity. In Chapter 3, the difference of such distribution between 
torafugu and red seabream, a typical fatty fish species, were compared. As expected, torafugu 
accumulated TAG predominantly in liver and hardly did in muscle, whereas red seabream did in liver, 
muscle, and adipose tissue. However, the TAG contents in their sera were not so different from each other. 
Blue-native polyacrylamide gel electrophoresis followed by Oil red O staining also revealed that there 
was no significant difference in lipid distribution among lipoproteins. Further analysis using 
high-performance liquid chromatography demonstrated that TAG amount of a fraction containing VLDL 
and LDL was significantly higher in torafugu than red seabream (39.4 ± 15.6 vs. 24.7 ± 12.3 mg/100 mL, 
respectively), whereas those in the HDL fraction were similar (54.0 ± 23.1 vs. 51.4 ± 14.0 mg/100 mL, 
respectively). Since VLDL and LDL are thought to be major TAG transporters in fish, these results 
suggest that the low TAG content in torafugu muscle is not derived from the little TAG secretion from 
liver and intestine, but probably from low TAG incorporation into the muscle cell. This is also supported 
by further experiments using ex vivo system showing that the gene expression of 14 kDa apolipoprotein 
(Apo-14), a homologue of mammalian apolipoprotein A-II, was up-regulated by high concentration of 
rtGH (200 ng/ml) in liver slices. This result implies that torafugu is capable of producing the lipoproteins 
in its liver in response to GH stimulation. 
 Finally, the results obtained in this study were summarized and future perspectives were 
proposed in general discussion. The present study elucidated the molecular mechanisms of GH to 
maintain lipid metabolism in torafugu, possibly with controlling the lipid contents in liver and muscle. 
The knowledge obtained in this study will help us to understand the overall function and importance of 
GH in teleost fish species. 
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Some parts of this thesis have been already published as follows: 
Hirano, Y., Kaneko, G., Koyama, H., Ushio, H., Watabe, S., 2011. cDNA cloning of two types of growth 
hormone receptor in torafugu Takifugu rubripes: tissue distribution is possibly correlated to lipid 
accumulation patterns. Fisheries Science. 77, 855–865 
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Chapter 1 
Effects of recombinant torafugu growth hormone on liver and muscle tissue metabolism 
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Chapter 2 
cDNA cloning and tissue distributions of two types of growth hormone receptor in torafugu 
 
 The biological action of GH is initiated by its binding to a specific receptor, the growth 
hormone receptor (GHR), located on the cell membrane of target tissues. After binding to GH, GHR is 
phosphorylated, resulting in activation of a cascade of signaling molecules, such as STAT, Akt, and ERK 
as mentioned in Chapter 1, that subsequently lead to the expression of target genes like transcription 
factors and metabolic enzymes. This entire process is called GH/GHR signaling (Herrington and 
Carter-Su, 2001). 
 GHR is a single transmembrane receptor protein belonging to the cytokine class I receptor 
superfamily. To date, cDNAs encoding GHR have been cloned from many kinds of vertebrates including 
various fish species (Reindl and Sheridan, 2012). Because of the genome duplication, almost all fish have 
at least two types of GHRs. One of the major functions of GH/GHR signaling is to up-regulate the 
expression of insulin-like growth factor-I (IGF-I), a peptide hormone having a critical role in somatic 
growth of vertebrates. IGF-I is involved in the regulation of metabolism as well as cell proliferation and 
differentiation, ultimately regulating body growth (Moriyama et al., 2000; Fuentes et al., 2013). This is 
called GH/IGF-I axis where GHR plays an important role. The previous studies using genetically 
modified mice revealed that the liver-specific deletion of GHR causes a 90% decrease in circulating IGF-I 
(Fan et al., 2009; List et al., 2014), indicating that the liver is the main target organ of GH to produce 
large quantities of IGF-I into circulation. 
 Several genes possibly related to growth rate in torafugu have been cloned including GH and 
IGF-I so far (Venkatesh and Brenner, 1997; Kaneko et al., 2011). Torafugu GHRs were also cloned in 
silico (Jiao et al., 2006; Kaneko et al., 2011), where the correlation of the mRNA expression levels of GH, 
GHR1, and IGF-I with growth rate has been insisted. Therefore, it is needed to confirm the actual 
 41 
sequences of torafugu GHRs by cDNA cloning for further understanding of torafugu GH/GHR signaling. 
Interestingly, torafugu is typical lean fish, which accumulates lipids specifically in liver and hardly in 
muscle. GH has been reported to have direct lipolytic effects in fish liver (O’ Connor et al., 1993; Bergan 
et al., 2013). It is also intriguing whether GH/GHR signaling involves such species-specific lipid 
accumulation patterns in fish. 
 In Chapter 2, cDNA cloning of torafugu GHRs were performed based on torafugu genome 
database. The comparison of deduced amino acid sequences with other vertebrates GHRs elucidated the 
characteristics of torafugu GHRs. The regulatory effects of GH on GHRs mRNA expressions in liver and 
muscle were also tested using ex vivo system. In addition, the capacity of torafugu liver to express the 
IGF-I gene responding to GH stimulation was demonstrated. 
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Section 1. cDNA cloning and sequencing analysis of two types of GHR in torafugu 
 
 In this section, two types of torafugu GHRs were cloned in silico using torafugu 
whole-genome database with human GHR sequence as a probe. Gene-specific primers were designed 
based on the sequences obtained from toraufug genome database and the cDNAs including ORF were 
cloned. The deduced amino acid sequences were subsequently used for the primary structure and 
phylogenetic analyses. 
 
Materials and methods 
cDNA cloning of torafugu GHRs 
A specimen of torafugu reared in The University of Tokyo was used for cDNA cloning (n=1, 
approximately 65 g). Total RNAs were extracted from the fast muscle of torafugu using ISOGEN 
(Nippon Gene, Toyama, Japan) and treated with DNase I (TaKaRa) according to the manufacture’s 
protocol. One µg of the total RNA was used as a template for the first-strand cDNA synthesis with 
Superscript III reverse transcriptase (Invitrogen) with an oligo(dT)20 primer (Invitrogen). Gene-specific 
primers GHR1F1, GHR1R1, GHR1F2, GHR1R2, GHR2F, and GHR2R were designed for cDNA cloning 
of GHR1 and GHR2 based on the JGI Fugu genome database version 4.0 (Table 2-1). 
For GHR1, PCR was performed in a 50 µl reaction mixture containing 1 µl of first-strand 
cDNA, 5 µl of 10 x PCR buffer, 5 µl of 2 mM dNTP mixture, 3 µl of 25 mM MgSO4, 20 pmol each of 
GHR1F1 and GHR1R1 primers, 13.2 µl of sterile distilled water, and 1 U of KOD-plus-ver.2 DNA 
polymerase (Toyobo). The PCR profile was as follows: 94˚C for 2 min, 30 cycles of 98˚C for 10 s, 57˚C 
for 45 s, and 68˚C for 2 min. The resulting products were purified using QIAquick PCR Purification Kit 
(Qiagen, Hilden, Germany) and used as templates for nested PCR using GHR1F2 and GHR1R2 primers. 
For GHR2, PCR was performed in the same reaction mixture as above except for GHR2F and GHR2R 
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primers. The PCR profile was as follows: 94˚C for 2 min, 35 cycles of 98˚C for 10 s, 56˚C for 30 s, and 
68˚C for 2 min. 
 
Rapid amplification of cDNA ends (RACE) 
To obtain the full sequence of the ORF of torafugu GHR2, 5’ RACE was carried out. Total 
RNAs were extracted from various tissues of torafugu using RNeasy Lipid Tissue Mini Kit (Qiagen). 
First-strand cDNAs were synthesized from 1 µg of the total RNAs using Superscript III reverse 
transcriptase and a gene-specific primer, GSP-GHR2-RT (Table 2-1). The subsequent products were 
purified using MinElute Reaction Cleanup Kit (Qiagen) and incubated with 15 U of terminal 
deoxynucleotidyl transferase (TdT) and 2.5 µL of 2 mM dCTP (Invitrogen) at 37 ˚C for 20 min to add an 
oligo(dC) tail at the 5’ end. PCR amplification was performed in 20 µl of a reaction mixture containing 1 
µl of the TdT-treated cDNA, 2 µl of 10 x PCR buffer, 1.6 µl of 2.5 mM dNTP mixture, 10 pmol each of 
Abridged Anchor Primer (AAP) and GSP-GHR2-R1 primer (Table 2-1), 13.3 µl of sterile distilled water, 
and 0.5 U Ex Taq DNA polymerase (Takara). The PCR profile was as follows: 94˚C for 5 min, 25 cycles 
at 94˚C for 30 s, 54˚C for 30 s, 72˚C for 45 s, followed by a final extension step at 72˚C for 7 min. 
Subsequently the nested PCR was performed in 25 µl of a reaction mixture containing 1 µl of the PCR 
products, 2.5 µl of 10 x PCR buffer, 2.5 µl of 2 mM dNTP mixture, 1.5 µl of 25 mM MgSO4, 10 pmol of 
Abridged Universal Amplification Primer (AUAP) and GSP-GHR2-R2 primer (Table 2-1), 6.6 µl of 
sterile distilled water, and 0.5 U of KOD-plus-neo DNA polymerase (Toyobo). The PCR profile was as 
follows: 94 ˚C for 2 min, 25 cycles of 98 ˚C for 10 s, 54 ˚C for 30 s, and 68 ˚C for 45 s. 
3’RACE of torafugu GHR2 was also carried out. First-strand cDNAs were synthesized from 1 
µg of the total RNAs by incubating with Superscript III reverse transcriptase and GeneRacer Oligo dT 
primer (Invitrogen) (Table 2-1). The following PCR was performed in 20 µl of a reaction mixture 
containing 1 µl of the cDNA, 2 µl of 10 x PCR buffer, 1.6 µl of 2.5 mM dNTP mixture, 10 pmol each of 
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GeneRacer 3’RACE primer (Invitrogen) and GSP-GHR2-F1 primer (Table 2-1), 13.3 µl of sterile 
distilled water, and 0.5 U Ex Taq DNA polymerase (Takara). The PCR profile was as follows: 94˚C for 5 
min, 30 cycles at 94˚C for 30 s, 50˚C for 30 s, 72˚C for 2 min, followed by a final extension step at 72˚C 
for 7 min. The resulting products were used as templates for the nested PCR in 25 µl of a reaction mixture 
containing 1 µl of the products, 2.5 µl of 10 x PCR buffer, 2.5 µl of 2 mM dNTP mixture, 1.5 µl of 25 
mM MgSO4, 10 pmol of GeneRacer 3’RACE Nested primer (Invitrogen) and GSP-GHR2-F2 primer 
(Table 2-1), 6.6 µl of sterile distilled water, and 0.5 U of KOD-plus-neo DNA polymerase (Toyobo). The 
PCR profile was as follows: 94 ˚C for 2 min, 30 cycles of 98 ˚C for 10 s, 50 ˚C for 30 s, and 68 ˚C for 2 
min. 
 
Sequence analysis 
The PCR products were ligated into pBluescript II KS (+) vector. The nucleotide sequences 
of purified plasmids were analyzed using a DNA sequencer ABI PRISM 3100 genetic analyzer. 
Subsequently the deduced amino acid sequences of GHR1 and GHR2 were determined. Signal peptides 
and transmembrane domains were predicted using SignalP version 3.0 
(http://www.cbs.dtu.dk/services/SignalP/) and TMHMM version 2.0 programs 
(http://www.cbs.dtu.dk/services/TMHMM/), respectively. N-glycosylation sites were predicted by using 
the software Gene Runner version 3.05 (Hasting Software, Hasting, USA). The exon-intron structures 
were determined with the Spidey program (http://www.ncbi.nlm.nih.gov/spidey/) using the genomic 
sequences of the GHR1 gene (GHR1) and GHR2 screened on the JGI Fugu genome database. The 
alignment of amino acid sequences was carried out by CLUSTAL W (Thompson et al., 1994). The 
phylogenetic tree of GHR was constructed using the maximum likelihood method on the MEGA v6.0 
software with the substitution model JTT + G + I, which was determined by the evaluation of best-fit 
substitution (Tamura et al., 2013). Bootstrap resampling analysis from 1,000 replicates was used to 
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evaluate internal branches. 
 
Results 
cDNA cloning of torafugu GHR1 and GHR2 
 The BLAST program was run on the JGI Fugu genome database using the deduced amino 
acid sequence of human Homo sapiens GHR (NM000163) (Amselem et al., 1991) as a probe to identify 
torafugu counterparts. Two putative GHRs with high scores and low expect values were found in 
scaffolds 11 and 128. Based on the nucleotide sequences of these two putative torafugu GHRs, 
gene-specific primer pairs were designed to amplify their ORFs (Table 2-1). DNA fragments consisting 
of 1914 bp and 1590 bp in ORF were amplified by PCR using primer pairs designed based on the 
sequences in scaffolds 11 and 128, respectively. Further investigation using 5’ RACE and 3’RACE 
revealed that the latter GHR had an additional 105 bp sequence containing 5’-untranslated region (UTR) 
and 5’-terminal ORF, and an additional 1024 bp sequence in 3’-UTR, yielding 1695 bp in the full-length 
ORF. 
 A phylogenetic tree was constructed by the maximum likelihood method based on the 
multiple alignment of deduced amino acid sequences of GHRs from torafugu, other fish, and several 
higher vertebrates, using the torafugu prolactin receptor (Lee et al., 2006) as the outgroup (Fig. 2-1). This 
analysis clearly showed that fish GHRs were clustered into two clades, namely GHR1 and GHR2. 
Torafugu GHRs in the longer and shorter ORF sequences were found to be categorized into GHR1 and 
GHR2, respectively. Fish GHR1 and GHR2 were both subsequently subdivided in two groups. One group 
was comprised of Perciformes and Pleuronectiformes, whereas the other of Siluriformes and 
Cypriniformes. Two GHR2 isoforms of Salmoniformes were monophyletic with the former group. Both 
torafugu GHRs also belonged to the former group. 
 The deduced amino acid sequence of torafugu GHR1 consisted of a signal peptide (23 aa), an 
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extracellular domain (234 aa), a single transmembrane domain (23 aa), and an intracellular domain (357 
aa) (Fig. 2-2). That of torafugu GHR2 consisted of a signal peptide (23 aa), an extracellular domain (221 
aa), a single transmembrane domain (23 aa), and an intracellular domain (297 aa) (Fig. 2-2). The multiple 
alignment of torafugu and other vertebrate GHRs revealed that torafugu GHR1 had several common 
features including a signal peptide, seven conserved extracellular cysteine residues, potential 
N-glycosylation sites, a GHR ligand-binding motif of FGEFS, nine conserved intracellular tyrosine 
residues, and box 1 and box 2 domains (Fig. 2-2). As for torafugu GHR2, it contained only five conserved 
extracellular cysteine residues and four conserved intracellular tyrosine residues. 
 The results from the phylogenetic analysis were consistent with the amino acid sequences 
identities of torafugu GHR1 and GHR2 with GHRs from other vertebrates. Torafugu GHR1 and GHR2 
always showed higher identity to fish ones than to other animal species GHRs including amphibians and 
mammals when compared using the mature receptor sequences or using extracellular and intracellular 
domains separately (Table 2-2 and 2-3). The approximate identities of torafugu GHR1 mature receptor 
with Perciformes, Pleuronectiformes, Siluriformes, and Cypriniformes were 70, 65, 40, and 50%, 
respectively, whereas those of torafugu GHR2 mature receptor with Periciformes, Salmoniformes, 
Siluriformes, and Cypriniformes were 60, 50, 40, and 40%, respectively. Meanwhile, those of torafugu 
GHR1 and GHR2 mature receptors with other animal species GHRs were only about 30%, which were 
lower than those with fish. As for GHR1, orange-spotted grouper counterpart showed the highest amino 
acid identity to torafugu one (70%), whereas the value between torafugu and orange-spotted grouper 
GHR2s was only 61%, suggesting that torafugu GHR1 is more conserved than torafugu GHR2. 
 Table 2-4 shows the amino acid sequence identities between the two GHR isoforms of each 
fish species in the mature form, extracellular domains, and intracellular domains. The amino acids 
identity of the extracellular domain was found to be higher than that of the intracellular domain in any 
fish compared irrespective of GHR1 and GHR2, indicating that the extracellular domain is more likely to 
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be conserved than the intracellular domain. Among these six species, the identity between the isoforms in 
intracellular domain was various (from lowest 28% in torafugu and zebrafish to highest 41% in 
orange-spotted grouper), although the identity in the extracellular domain was similar (41, 46 and 45% in 
torafugu, zebrafish and orange-spotted grouper, respectively). Torafugu GHR isoforms in the mature form 
showed the lowest identity between each other among six fish species compared in this study. 
 Genomic organizations of torafugu GHR1 and GHR2 were revealed based on the Fugu 
genome database together with the cDNA sequences obtained in the present study (Fig. 2-3). The 
information of genomic DNA sequence is also available on Ensemble database with ensemble IDs 
ENSTRUG00000015040 and ENSTRUG00000013005 for scaffold 11 and 128, respectively. The 
genomic DNA of torafugu GHR1 was composed of nine exons, where exon 1 coded for the signal peptide, 
exons 2-5 for the extracellular domain, exon 6 for the transmembrane domain, and exons 7-9 for the 
intracellular domain. As for torafugu GHR2, the genomic DNA was composed of eight exons, where 
exons coded for the corresponding domains as GHR1 except that the intracellular domain of GHR2 was 
encoded by exon 7-8. There were the largest intron sizes between exons 1 and 2 in both torafugu GHRs 
genomic DNAs. Comparison of the genomic structure of GHRs between torafugu and zebrafish 
elucidated that the corresponding translated regions between torafugu and zebrafish GHRs are encoded by 
the same exons. 
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Section 2. Tissue distributions of torafugu GHR1 and GHR2  
 
 As mentioned in General introduction, the abundance of GHR would determine the GH 
responsiveness of each tissue. In this section, the mRNA expression levels of torafugu GHR1 and GHR2 
in various tissues were measured by quantitative real-time PCR to estimate their GH sensitivity. 
 
Materials and methods 
Fish 
 Torafugu whose tissues were used for reverse transcription (RT)-PCR followed by 
quantitative real-time PCR (n=4, average body weight 1,100 g) were obtained from a commercial dealer 
(Fish Interior). Before sampling, they were reared in a 1-t tank for 1 day in The University of Tokyo. 
After anesthesia with ice-cold seawater for approximately 15 min, various tissues were dissected and 
stored in RNA later at -80 ˚C until RNA extraction. Samples dissected from dorsal white and erector 
depressor slow muscles at the base of the dorsal fin were used as fast muscle and slow muscle, 
respectively. 
 
Quantitative real-time PCR for tissue distributions of GHR1 and GHR2 
The relative mRNA levels of GHR1 and GHR2 were analyzed by quantitative real-time PCR 
with an ABI PRISM 7300 real-time PCR system. Those of torafugu β-actin were used as the internal 
control. The gene-specific primer pairs were used for GHR1 (GHR1 real-time F and GHR1 real-time R) 
and β-actin (β-actin real-time F and β-actin real-time R) (Kaneko et al., 2011), whereas those for GHR2 
(GHR2 real-time F and GHR2 real-time R) were designed using the Primer Express software version 2.0 
(Table 2-1). The quantitative PCR was performed in a 20 µl reaction mixture that contained 2 µl of cDNA 
(1:10 dilution), 0.4 µl of 50 x ROX Reference Dye (Takara), 10 pmol each of gene-specific primers, and 
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10 µl of 2 x SYBR Premix Ex Taq (Takara). The PCR profile was as follows: 95˚C for 30 s, 40 cycles at 
95˚C for 5 s and 60˚C for 31 s. The absence of non-specific PCR products was verified by running the 
dissociation protocol (95˚C for 15 s, 60˚C for 30 s, and 95˚C for 15 s). The relative mRNA levels were 
calculated by the comparative Ct method with reference to those of β-actin as the internal control. The 
resulting data were analyzed by one-way analysis of variance (ANOVA) followed by Tukey-Kramer 
post-hoc test. 
 
Results 
Tissue distribution of torafugu GHR1 and GHR2 
 The reverse transcribed cDNAs from various tissues including gill, heart, skin, fast muscle, 
slow muscle, liver, and intestine were used for RT-PCR followed by quantitative real-time PCR. The 
transcripts of torafugu GHR1 and GHR2 were obtained by both RT-PCR and quantitative real-time PCR 
in all tissues examined (data not shown for RT-PCR). In detail results of the relative mRNA levels of 
torafugu GHR1 and GHR2 obtained by quantitative real-time PCR was shown in Fig. 2-4. Statistically 
significant difference in the relative mRNA levels of GHR1 and GHR2 among these tissues was shown 
by One-way ANOVA (p < 0.05). Subsequent Tukey-Kramer HSD post-hoc test revealed that fast muscle 
accumulated significantly highest relative mRNA level of GHR1 than those in other tissues (p < 0.05). On 
the other hand, no significant difference was observed in the relative mRNA level of GHR2 among all 
tissues examined. 
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Section 3. The effects of rtGH on torafugu GHRs and IGF-I gene expressions 
 
 Some previous reports showed that GH regulates GHR expression in fish hepatocytes (Very 
and Sheridan, 2007; Pierce et al., 2012). In this section, the rtGH potency to regulate the gene expressions 
of GHR1 and GHR2 in torafugu liver and muscle slices was evaluated. As for liver, many fish species are 
reported to up-regulate IGF-I gene expression responding to GH stimulation (Pierce et al., 2004; Leung et 
al., 2008; Pedroso et al., 2009; Pierce et al., 2011; Reindl et al., 2011). To reveal whether torafugu liver 
also shows the similar response to GH, the IGF-I gene expressions in liver slices treated with different 
rtGH concentrations were confirmed. 
 
Materials and methods 
Preparation of recombinant torafugu GH and liver slices for tissue culturing 
 The detailed methods for the preparation of rtGH and tissue culturing of liver and muscle 
were described in Chapter 1. The purified rtGH dissolved in hyperosmolar PBS were added to culture 
wells to achieve the desired final concentrations (5 ng/ml and 200 ng/ml). Control cultures received an 
equivalent volume of hyperosmolar PBS. The liver samples were then collected after 12 and 24 hours of 
rtGH addition. The slices were immersed in RNA later and stored at -20˚C. 
 
Quantitative real-time PCR for tissue culture experiments 
 The total RNAs were extracted from tissue slices and reverse transcribed as described in 
Chapter 1. For each gene, the gene-specific primers and TaqMan probes were designed using Primer 
Express software version 2.0 as listed in Table 2-1. The enzyme and profile used for real-time PCR was 
the same as those used for evaluating the gene expressions in Chapter 1. Relative mRNA levels were 
determined by the comparative Ct method with reference to those of EF-1α as the internal control. 
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Statistical analysis 
 Data are expressed as means ± SE. Statistical differences of the relative mRNA levels 
between control and rtGH treatment groups were determined by Student’s t-test or Welch’s t-test after 
F-test for two means. 
 
Results 
The effects of rtGH on the gene expressions of GHR1 and GHR2 in torafugu liver and muscle 
 The quantitative real-time PCR for GHR1 and GHR2 was performed using the liver and 
muscle slices treated with rtGH at final concentration of 5 ng/ml. The gene expression changes were 
evaluated after 12 and 24 hours of rtGH addition (Fig. 2-5). There was no significant change in the gene 
expressions of both GHR1 and GHR2 irrespective of the tissue slices by rtGH treatment. 
 
The effects of rtGH on the gene expressions of IGF-I in torafugu liver 
 The relative mRNA levels of IGF-I in the liver slices treated with rtGH at two different 
concentrations (5 and 200 ng/ml) were measured by quantitative real-time PCR. The gene expression 
change was evaluated after 12 and 24 hours of rtGH addition (Fig. 2-6). At both concentrations of rtGH 
treatment, there was no significant change in the gene expression of IGF-I in liver slices. 
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Section 4. Discussion 
 
 There have been many reports identifying the two distinct GHRs in teleosts (Reindl and 
Sheridan, 2012). In this study, the two types of cDNAs coding torafugu GHRs were cloned, both of 
which had conserved regions in extracellular and intracellular domains. In the extracellular domain, the 
ligand-binding motif (FGEFS) was found as in the cases of frog, chicken and almost all fish species 
reported so far (Fig. 2-2). It is noted that this motif is substituted to YGEFS in human, YSGFS in mouse, 
and EGGFS in turtle. In the intracellular domain, the sequences corresponding to box 1 and box 2 were 
found in torafugu GHRs. Box1 is revealed as a site for JAK2 binding in human GHR, whereas box 2 is 
involved in the proliferative response (Frank et al., 1994; Ihle et al., 1995). The observation that those 
regions were highly conserved in torafugu GHRs suggests that a signaling pathway downstream of GHRs 
similarly function in torafugu as in other animals. 
 Torafugu GHR1 had seven conserved extracellular cysteine residues (Fig. 2-2). When 
compared with human GHR, the three pairs of these extracellular cysteine residues, C52/C62, C97/C107, 
and C121/C137 are expected to form disulfide bonds. Human GHR has been revealed to dimerize via 
binding to GH and form an intermolecular disulfide bond between the unpaired cysteine residues of two 
GHR molecules (Zhang et al., 1999). It remains to be elucidated whether torafugu GHR counterpart, 
C229, the last unpaired cysteine residues, also participates in dimerization. Meanwhile, six potential 
N-glycosylation sites were found in the extracellular domain of torafugu GHR1. The involvement of GHR 
glycosylation in an affinity efficiency of GHR to GH and in GH-GHR complex internalization is claimed 
in a previous study (Harding et al., 1994). There were nine tyrosine residues in the intracellular domain in 
torafugu GHR1. Such tyrosine residues in the intracellular domain are probably phosphorylated after 
dimerization and subsequently activate the downstream signaling molecules based on the mammalian 
GHR investigations (Wang et al., 1996; Hansen et al., 1997). 
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 On the other hand, torafugu GHR2 lacked two extracellular cysteine residues compared with 
torafugu GHR1 (Fig. 2-2): the cysteine residues corresponding to C121 and C137 in GHR1 were not 
observed in GHR2. It is expected that torafugu GHR2 has less numbers of intramolecular disulfide bonds 
than GHR1. Torafugu GHR2 also lacked three N-glycosylation sites and five intracellular tyrosine 
residues compared with torafugu GHR1. The less numbers of these residues in torafugu GHR2 might 
cause less efficient function in GH/GHR signaling. Actually, a previous report investigating black 
seabream Acanthopagrus schlegeli showed that the receptor-mediated promoter activation by GHR2 was 
much lower than that of GHR1 that were over-expressed in cultured Chinese hamster ovary cells (Jiao et 
al., 2006). The amino acid identities between GHR1 and GHR2 in the same fish species revealed that 
torafugu GHRs were less similar than black seabream GHRs (Table 2-4), suggesting that torafugu GHR1 
and GHR2 also have different functions in GH/GHR signaling. 
 Torafugu GHRs identified in this study were clearly clustered into different clades, fish 
GHR1 and GHR2 (Fig. 2-1). Torafugu belongs to Tetraodonitiformes and its two GHRs were divided into 
those from Perciformes and Pleuronectiformes, indicating the evolutionarily close relationship among 
these species than the other three groups including Siluriformes, Cypriniformes, and Salmoniformes. The 
amino acid identities between GHR1 and GHR2 in the same fish species showed that the identity of the 
extracellular domain of GHRs was higher than that of the intracellular domain in six fish species 
examined (Table 2-4), indicating that the extracellular domain is more conserved than the intracellular 
domain evolutionarily. The exon-intron organization was remarkably similar between torafugu GHR1 and 
GHR2 (Fig. 2-3), where the regions encoding the signal peptide and the transmembrane domain were 
located at exon 1 and 6, respectively. This organization was almost the same as in zebrafish GHRs 
(Prinzio et al., 2010), suggesting the highly conserved genomic organizations of GHRs in fish. 
 The mRNA expressions of both torafugu GHR1 and GHR2 were observed in all tissues 
examined at different levels (Fig. 2-4). The higher relative mRNA levels of both transcripts were detected 
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in fast muscle, slow muscle, and liver. Especially, the significantly highest relative mRNA level of 
torafugu GHR1 was observed in fast muscle. The expression level of GHR is generally higher in liver 
than that in muscle in various fish species (Tse et al., 2003; Jiao et al., 2006; Small et al., 2006; Fuentes et 
al., 2008; Walock et al., 2013). In this regard, it is interesting that the relative mRNA level of GHR1 in 
muscle was higher than that in liver from torafugu. A previous study using gene modified mice showed 
that the liver-specific GHR deficiency causes hepatic steatosis, implying that the remarkable lipid content 
in torafugu liver is derived from the relatively lower GHR expression in torafugu liver. The ex vivo 
experiments revealed that the gene expression of GHR1 and GHR2 in liver and muscle slices were not 
significantly changed by rtGH (Fig. 2-5). Actually, the previous studies investigated the effect of GH on 
GHR expression in several fish species, but the results are conflicting. The GHR1 and GHR2 expressions 
in isolated rainbow trout hepatocytes are significantly up-regulated by trout GH (Very and Sheridan, 
2007), whereas only the expressions of GHR2 is strongly stimulated by native tilapia GH in primary 
cultured tilapia hepatocytes (Pierce et al., 2012). The in vivo GH treatment in black seabream does not 
show any change in the gene expression levels of GHR1 and GHR2 (Jiao et al., 2006). Taking these 
reports into account, the results obtained in this study suggest that the effect of GH on GHR expression is 
species-specific and that the highest expression of GHR1 in torafugu muscle is possibly regulated by 
other factors, such as hormones other than GH and/or sex steroids (Reindl et al., 2012). It is required to 
identify the main factor which maintaining the GH/GHR signaling in torafugu whole body. 
 The ex vivo experiments also revealed that the gene expression of IGF-I in torafugu liver 
slices did not changed by rtGH treatment at both low and high concentration (5 and 200 ng/ml, 
respectively) (Fig. 2-6). In contrast to the GHR expression, the results obtained from the previous studies 
investigating the GH effect on IGF-I expression in fish liver are consistent with each other. Namely, the 
GH treatment significantly up-regulates the IGF-I expression in teleost hepatocytes (Pierce et al., 2004; 
Leung et al., 2008; Pedroso et al., 2009; Pierce et al., 2011; Reindl et al., 2011). In this study, the IGF-I 
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gene expression was not regulated by rtGH treatment in torafugu liver slices although its concentration 
used in this study was comparable to the previous studies. This result suggests that the torafugu liver has 
low GH sensitivity with regard to IGF-I production compared to other fish species, possibly reflecting the 
relatively lower expression of GHRs. The tissue distribution of IGF-I in torafugu tissues was investigated 
only by reverse transcribed PCR (Kaneko et al., 2011). The detailed information of IGF-I tissue 
distribution with quantitative real-time PCR will provide us the correlation between GHR and IGF-I gene 
expressions in various tissues. 
 In conclusion, two kinds of GHR, GHR1 and GHR2, were cloned from torafugu in this study. 
The amino acid sequences of functionally important regions were highly conserved with other vertebrates 
in both GHR1 and GHR2. As for GHR1, the low relative mRNA level in liver compared to that in 
skeletal muscle was observed by quantitative real-time PCR. The ex vivo experiments showed that the 
rtGH did not regulate the gene expression of IGF-I in torafugu liver slices. These results suggest that 
torafugu has low GH sensitivity in liver, probably relating to its high lipid content.
Table 2-1. Sequences of primers used in cDNA cloning, RT-PCR and quantitative real-time PCR
Primer name Sequence (5' - 3') Gene Tissue 
For cDNA cloning 
GHR1F1 GCTCTGATTCTCTCCGCAGCATC  GHR1 - 
GHR1R1 CTGAAGGTCTAAGGCTAGTGTCAC GHR1 - 
GHR1F2 CGCAGCATCATGGCTGTCTCC GHR1 - 
GHR1R2 GTCACTTTAACGGGACAGGTTCC GHR1 - 
GHR2F GGTCCGTCTCCACACATCACC GHR2 - 
GHR2R CTATGGGGTGATGCTTCCCAAAAGATCAGG GHR2 - 
For 5' RACE 
GSP-GHR2-RT TCCTCGGCCCAGGAACAGGTGGCAAAAG GHR2 - 
GSP-GHR2-R1 GTCAGCTCCTGCGGAGGGTCTGGTTGTA GHR2 - 
GSP-GHR2-R2 ATGGTGTAAATGTCCAGACG GHR2 - 
AAP GGCCACGCGTCGACTAGTACGGGIIGGGIIGGGIIG - - 
AUAP GGCCACGCGTCGACTAGTAC - - 
For 3' RACE 
GeneRacer Oligo dT GCTGTCAACGATACGCTACGTAACGGCATGACAGTG(T)24 GHR2 - 
GeneRacer 3'RACE GCTGTCAACGATACGCTACGTAACG GHR2 - 
GSP-GHR2-F1 GAGTCCGCTGCAAAACTCTC GHR2 - 
GeneRacer 3'RACE Nested CGCTACGTAACGGCATGACAGTG GHR2 - 
GSP-GHR2-F2 TCATGCAACCCTCACTCTTG GHR2 - 
For quantitative real-time PCR for tissue distributions 
GHR1 real-time F AGAGTACGAGGTGCACATTCGTT GHR1 - 
GHR1 real-time R AGTCGCTGAATTCTCCAAACTTTT GHR1 - 
GHR2 real-time F GCAGGAAAAGTTGATGGTTCTTCTT GHR2 - 
GHR2 real-time R TTTGAGTCGACCCCTCTTATCC GHR2 - 
β-actin real-time F CGCCGCACTCGTTGTTG b-actin - 
β-actin real-time R CTCCAGCAAATCCGGCTTT b-actin  - 
For quantitative real-time PCR of tissue culture samples 
GHR1 real-time F1 ATTGAAGTGACTGAAATTCCCATC GHR1 L/- 
GHR1 real-time F2 TGAAGTGACTGAAATTCCCATCA GHR1 -/M 
GHR1 real-time R1 ATACTGACGGCCCCAAACAC GHR1 L/- 
GHR1 real-time R2 TACTGACGGCCCCAAACAC GHR1 -/M 
GHR1 real-time probe AGTCTCCCTTCTCTCTCACCCTGGCACT GHR1 L/M 
GHR2 real-time F1 GCAGCAAAAGTTGATGGTTCTTCTT GHR2 L/- 
GHR2 real-time F2 TTGTCCACATCCCGTCCAA GHR2 -/M 
GHR2 real-time R CAATTTTGAGTCGACCCCTCTT GHR2 L/M 
GHR2 real-time probe TGCCACCTGTTCCTGGGCCG GHR2 L/M 
IGFI real-time F GGAAGTGCATCAGAAAAACTCAAG IGF-I L/- 
IGFI real-time R ATTCGCTCCTCGCCTACATTC IGF-I L/- 
IGFI real-time probe TCGAGGCAATGCGGGTGGC IGF-I L/- 
qRT-EF-1a-F1 CGTTGTTGGCGACAGCAA EF-1a L/M 
qRT-EF-1a-R1 TGATGACCTGGGCATTGAAG EF-1a L/M 
qRT-EF-1a-R2 ATGATGACCTGGGCATTGAAG EF-1a L/- 
qRT-EF-1a-probe AACGACCCACCAAAGGGAGCTGACA EF-1a L/M 
AAP, Abridged Anchor Primer; AUAP, Abridged Universal Amplification Primer. L, primes and probes used for liver 
samples; M. primers and probes used for muscle samples. 
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Table&2(2.&Amino&acid&sequence&iden..es&of&torafugu&GHR1&with&those&from&other&ﬁsh&and&torafugu&GHR2&and&PRLR&
Species& Accession&No.& Amino&acid&iden.ty&
Mature& Extracellular& Intracellular&
form& domain& domain&
GHR1&
OrangeHspoIed&grouper& EF052273& 70& 78& 66&
Gilthead&seabream&& AF438176& 69& 77& 65&
Black&seabream&& AF502071& 69& 78& 65&
Turbot&& AF352396& 66& 75& 61&
Japanese&ﬂounder&& AB058418& 65& 73& 63&
Nile&.lapia& AY973232& 64& 73& 59&
Goldﬁsh&& AF293417& 48& 55& 45&
Rohu&& AY691177& 49& 53& 47&
Catla&& AY691178& 49& 53& 47&
Ca[ish&& AY336104&& 42& 52& 39&
Zebraﬁsh& EU649774& 42& 54& 38&
GHR&
Frog& AF193799&& 32& 41& 27&
Turtle&& AF211173& 33& 41& 30&
Chicken&& NM001001293& 33& 39& 30&
Rat&& NM017094&&& 31& 38& 27&
Mouse&& NM010284&& 32& 38& 28&
Rabbit&& NM001082636& 31& 38& 28&
Cow&& NM176608& 31& 39& 27&
Sheep& NM001009323& 32& 40& 27&
Human& NM000163& 31& 35& 28&
Others&
Torafugu&PRLR&& NP001072093&& 22& 28& 16&
Torafugu&GHR2& AB621337& 34& 41& 28&
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Table&2(3.&Amino&acid&sequence&iden..es&of&torafugu&GHR2&with&those&from&other&ﬁsh&and&torafugu&GHR1&and&PRLR&
Species& Accession&No.& Amino&acid&iden.ty&
Mature& Extracellular& Intracellular&
form& domain& domain&
GHR2&
OrangeHspoIed&grouper& EF052274& 61& 63& 58&
Gilthead&seabream& AY573601& 60& 61& 57&
Black&seabream&& AF662334& 59& 61& 57&
Nile&.lapia& AY973233& 55& 55& 53&
Coho&salmon&isoform&1& AF403539&& 48& 53& 44&
Coho&salmon&isoform&2& AF403540&& 49& 51& 47&
Ca[ish&& AY97323& 41& 43& 38&
Zebraﬁsh& EU649775& 38& 43& 34&
GHR&
Frog&& AF193799&& 30& 35& 28&
Turtle&& AF211173& 31& 36& 28&
Chicken&&&&&&&&& NM001001293& 30& 34& 28&
Rat&& NM017094&& 29& 35& 29&
Mouse&& NM010284&& 31& 33& 29&
Rabbit&& NM001082636& 31& 36& 29&
Cow&& NM176608& 33& 37& 30&
Sheep& NM001009323& 33& 36& 30&
Human& NM000163&& 31& 36& 28&
Others&
Torafugu&PRLR& NP001072093&& 23& 29& 19&
Torafugu&GHR1& AB621336& 34& 41& 28&
58
Table&2(4.&Amino&acid&sequence&iden..es&between&GHR1&and&GHR2&in&ﬁsh&
Species& Mature& Extracellular& Intracellular&
form& domain& domain&
OrangeHspoIed&grouper& 43& 45& 41&
Gilthead&seabream& 42& 46& 39&
Black&seabream&& 41& 46& 38&
Nile&.lapia& 38& 44& 33&
Zebraﬁsh& 36& 46& 28&
Torafugu& 34& 41& 28&
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Fig. 2-1. The phylogenetic tree constructed by MEGA v6.0 using the maximum likelihood method based on the 
deduced amino acid sequences of GHRs from vertebrate animals. The bootstrap values from a 1,000-replicate 
analysis are given at the nodes in percentage. The scale bar, phylogenetic distance of 0.5 amino acid substitution 
per site. The accession numbers of proteins in the NCBI database are shown in Table 2-2 and 2-3. 
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Torafugu GHR1   -----------MAVSSSSFSPCLLLLLFLISSLSWVSNRSSAFLMERG--------------    37 Gilthead GHR1   MAVFSSSSSSSSSS....S.TSN....L.V...D.L.T.G.V.V.DH---------------    47 Torafugu GHR2   ------------MCPQINSMAAAAAA.IQF.C.HA.PPAVLGSALH.---------------    35 Gilthead GHR2   -------------------MAAA.T...CLYI.TSSALE.ASEQVHP---------------    28 Frog GHR        ---------------------MAYW.FWVTVI.LYIDGSTA.T-------------------    22 Turtle GHR      ---------------------MD.WQ.L..LV.VCADSSL..G-------------------    22 Chicken GHR     ---------------------MD.RH.LFTLA.VCANDSL..S-------------------    22 Mouse GHR       ---------------------MD.CQV..TLA.AVT.STF.GSEATPATLGKASPVLQRINP    41 Human GHR       ---------------------MD.WQ.L.TLA.AGS.DAF.GSEATAAILSRAPWSLQSVNP    41 
Torafugu GHR1   GATSSAPYEPHFTECVSRNQETFQCWWSLGSFHNLSLPGALRVFYLKRESGSL--------V    91 Gilthead GHR1   -M.....VG......I..E....R....P.G.....S..........KD.P----------N    98 Torafugu GHR2   ------GPS..I.S...A.M...H.R.NVS.LQ----S.D..L..INKKHPQTP-------P    80 Gilthead GHR2   ------QRD..L.G...A.M...R.R.NV.TLQ...K..E..L..INKL.PLDP-------P    77 Frog GHR        ---DVSLGK.RIIK.R.PQ...IT.Y.TN.E.R....S.L.KLQ.K.KT------------E    69 Turtle GHR      ---EVILGR..TIK.R.PE....S.H.TDKD....TA..TIQLL.MR.N------------D    69 Chicken GHR     ---DDLLQW.QISK.R.PEL...S.Y.TD.---KVTTS.TIQLL.M..S------------D    66 Mouse GHR       SLGT.SSGK.R..K.R.PEL...S.Y.TE.DNPD.KT..SIQLY.A....QRQAARIAHEWT   103 Human GHR       .LKTNSSK..K..K.R.PER...S.H.TDEVH.GTKNL.PIQL..TR.N--------TQEWT    95 
Torafugu GHR1   NEWKECPKYIHSN-RECFFDKNHTSVWTNYCMQLRSHN-VTYSDQDYCFFVENIVRPDPPVS   151 Gilthead GHR1   S......E.S.LK-......V......IP......GQ.N...L.E....T............   159 Torafugu GHR2   ...R...H.SAQSPN.....E...T...F.TI....GD-QSIIYDENIID.AD..Q....QE   141 Gilthead GHR2   K..T...H.SIDRPN....N........P.KV....RD-ESTLYDENT.T.DA..Q.....D   138 Frog GHR        AN.TD..DT.TGGENS.Y.S.TY..I.VS..TK.V.ED---TEFD....S.DD..E....MA   128 Turtle GHR      E......D..TAGENS.Y.NTSY..I.IT..VK.INKD---DVLDEK..S.DE..Q.....G   128 Chicken GHR     ED.....D..TAGENS.Y.NTSY..I.IP..VK.ANKD---EVFDEK..S.DE..L.....H   125 Mouse GHR       Q......D.VSAGKNS.Y.NSSY..I.IP..IK.TTNG---DLLDQK..T.DE..Q....IG   162 Human GHR       Q......D.VSAGENS.Y.NSSF..I.IP..IK.T.NG---GTVDEK..S.DE..Q....IA   154 
Torafugu GHR1   LNWTLLNISPSGLSYDVIVNWEPPPSADVKAGWMRIEYEIQYRERNSTNWEALEVQRHTHQT   213 Gilthead GHR1   .................M...........G............T...T.......M.P..Q..   221 Torafugu GHR2   .T.....Q.VTSTYS.IMLS.K..E....EM..L.LL..V...NMDIEQ.QVTDLVKS.SR.   203 Gilthead GHR2   .T..T..E.L..TY..I.LS.K..Q....AM...TLQ..V...SAS.DL.H.V.PVTV.QRS   200 Frog GHR        ....V....LTRMRI.IQLS.........SS..ISL...VHIK.A.ESQ.TI.DKVQTKYLP   190 Turtle GHR      .......T.LTRIHA.IQ.R.D.......QK..ITL...L..K.V.E.K.RE..PMLT.VVP   190 Chicken GHR     .......T.QT.IHG.IQ.R.D...T...QK..ITL...L..K.V.E.K.KE..PRLS.VVP   187 Mouse GHR       .........LT.IRG.IQ.S.Q...N...LK..IIL......K.V.ESK.KVMGPIWL.YCP   224 Human GHR       .......V.LT.IHA.IQ.R..A.RN..IQK...VL...L..K.V.E.K.KMMDPILT.SVP   216 
Torafugu GHR1   IYGLTIGKEYEVHIRCRMQAFQKFGEFSDSILIEVT------EIPIRESPFSLTLALVFGAV   269 Gilthead GHR1   ....Q................V........VF.Q..------...SQD.N.PFK...I..VL   277 Torafugu GHR2   L...KSNVD...RV..KTLGGKA.......VFVH---------..SKV.H.PALAL.I...L   256 Gilthead GHR2   LF..KHNVNH..RV..K.L.GKE........FVH---------..AKV.S.PVVAL.L...L   253 Frog GHR        V.A.KT..D.FARV..KQLSNG.......VLH.PLS-----ILPEPDLPDVPFL.F.II.LF   247 Turtle GHR      L.S.KL.RD..IRV.S.QR.SE...G..ETLYVSLS--SISSVLCDE.IQ.PWL.II...TF   250 Chicken GHR     L.S.KM.RD..IRV.S.QRTSE......EILYVSF.QAGIEFVHCAE.IE.PWF.VV...VC   249 Mouse GHR       V.S.RMD..H..RV.S.QRS.E.YS...EVLRVIFP-QTNIL.ACEEDIQ.PWF.III..IF   285 Human GHR       V.S.KVD.....RV.SKQRNSGNY....EVLYVTLP-QMSQFT-CEEDFY.PWL.III..IF   276 
Torafugu GHR1   SILVLIVLVAVSQQQRLMMILLPPVPAPKIKGINPELLKKGELDDLNFILSSGGMGSLPSYA   331 Gilthead GHR1   G..I..L.IGI...P..................D.......K..E......G....G.ST..   339 Torafugu GHR2   CVVAILM...IL..EK..VL......G.R.R.VDSK.....K.RE.TS..G.P-----LDLR   313 Gilthead GHR2   CLVAILM..II...EK..F.......G...R..D.......K.RE.TS..GGP-----.NLR   310 Frog GHR        GM.LVFIFIL.FKKK..K..I.....V......D.D..QR.K..EV.S..ACH-----DH.K   304 Turtle GHR      GLI.VMF.ILF.KHR..K.LI............D.D.....K..EV.S..ANH-----D..K   307 Chicken GHR     GLA.TAI.ILL.K.P..K.LIF....V......D.D.....K..EV.S..A.H-----DN.K   306 Mouse GHR       GVA.MLFV.IF.K...IK.LI.....V......D.D...E.K.EEV.T..GIH-----DN.K   342 Human GHR       GLT.MLFVFLF.K...IK.LI.....V......D.D...E.K.EEV.T..AIH-----D..K   333 
Torafugu GHR1   PEFYRDEPWVEFIEVDVEEGDAGEKLNSRDSDTLKLLGLPLSVSHSVNTMGSN-TISIPHDD   392 Gilthead GHR1   .D..Q...........A.DA..A..EENQG...QR..DP.QP...HM..GCA.-AV.F.D..   400 Torafugu GHR2   S.L.NND......DL.I..----------TTSR..D.DPDCLMQP.LLSDCTPPIF.FRD..   365 Gilthead GHR2   ..L.NND......DL.I..----------Q..K.TD.DTDCLMHR.LSSNCTPVS.GFRD..   362 Frog GHR        QQL.N.D.......L.LDDT------------DE.NE.SDTDRLLGEEHRKNHNCLGVKD..   354 Turtle GHR      .QL.N.NS......L.IDDP------------DE.TE..DTDRLLGD.HCK.HNCLGVKD..   357 Chicken GHR     TQL.N.DL......L.IDDS------------DE.NRVSDTDRLL.DDHLK.HSCLGAKD..   356 Mouse GHR       .D..N.DS......L.ID.A.----------VDE.TE.SDTDRLL.NDHEK.AGILGAKD..   394 Human GHR       ...HS.DS......L.ID.P------------DE.TEESDTDRLL.SDHEK.HSNLGVKDG.   383 
Torafugu GHR1   SGHISFYDPETFNPDT--------------------------------------QVLMGALL   416 Gilthead GHR1   ..RA.C...DLHDQ..--------------------------------------LM..AT..   424 Torafugu GHR2   ..RA.CC..DLSSEPE--------------------------------------ASTVHPAI   389 Gilthead GHR2   ..RA.CC..DLPSDPE--------------------------------------ASPFHP.I   386 Frog GHR        ..RA.CCE.DIPET.FSNSDTCDGTSDLGQTQNVKENEADLLCLDEKSNSVSPTN.SVPNTE   416 Turtle GHR      ..RA.CCE.DIPET.FSASDTCDGTSDIDQSKKTSEKEEDLLCLDQKDNNESHASPDDPTAQ   419 Chicken GHR     ..RA.C.E.DIPET.FSASDTCDAISDIDQFKKVTEKEEDLLCLHRKDDVEALQSLANTDTQ   418 Mouse GHR       ..RT.C...DILDT.FHTSDMCDGTLKFAQSQKLN-MEADLLCLDQKNLKNLPYDASL.S.H   455 Human GHR       ..RT.CCE.DILET.FNANDIHEGTSEVAQPQRLK-GEADLLCLDQKNQNNSPYHDACP.TQ   444 
Torafugu GHR1   PSQAEEDSSKDGSVTGSPSQDTRKTPGVQGQAGGAQTWVNTDFYAQVSNVMPSGGVVLSPGQ   478 Gilthead GHR1   .G.P.DGEDSFDV.ERA.VIERSER.L..T.T..P...L.......................   486 Torafugu GHR2   LN.VINQTFCSTGCA..GLL--NQ..N.SET----E.LDREAL.T...E.RST.K.L...--   443 Gilthead GHR2   .N.TLSKEVSCQTASEPS.P--VQS.ASGEPP--FAALGREAM.T...E.RS..K.L...--   442 Frog GHR        DG--SPKPEAEKTCPVAV.ENEPTSLP.SAPISKMRAKPSM....L..DIT.A.RLL.....   476 Turtle GHR      KPNTNIQ.EDNQ.KLPFADSIESTR.P.HT.LSNQSSGA...........T.A.S.......   481 Chicken GHR     QPHTSTQ.ESRE.WPPFADSTDSAN.S..T.LSNQNSLT.........DIT.A.S.......   480 Mouse GHR       ..-ITQTVEENKPQPLLS.ETEATHQLASTPMSNPTSLA.I.......DIT.A.........   516 Human GHR       QP-SVIQAE.NKPQPLPTEGAESTHQAAHI.LSNPSSLS.I.......DIT.A.S.......   505 
Torafugu GHR1   QLRIQESMAATKVEKQKKAKDPEDGEDAEDKKEGEQRPQVLLMDPEGSGYTTESSARQFNTP   540 Gilthead GHR1   ...F...TS.AED.A...G.G---S..S.E.TQK.LQF.L.VV...........N...IS..   545 Torafugu GHR2   ---------ELEKISSS.G---------MPLENEGKDLHI.VVNAHHG----SNM.GNVSQT   483 Gilthead GHR2   ---------EEQT.VE.TTGKDTEKDIMAE.EKAKKEF.L.VVNADHG...S.LN.GKMSPR   495 Frog GHR        RMK---NENEECNQPVIQHPANLNPDSPYICESAVTAFCAASKPRDTEASVKPN-VIDDSYF   534 Turtle GHR      TNKRRRTQCEAYT.PAIPCQPNFTTDY.YFCEADVKKCIAVTSCDAVEPHAQ.Q.FNEDVYF   543 Chicken GHR     KSKVGRAQCESCT.------QNFTMDN.YFCEADVKKCIAVISQE.DEPRVQ.Q.CNEDTYF   536 Mouse GHR       KIKAGIAQGN.QR.VATPCQENYSMNS.YFCESDAKKCIAVAPRM.ATSCIKP.FNQEDIYI   578 Human GHR       KNKAGM.QCDMHP.MVSLCQENFLMDN.YFCEADAKKCIPVAPHIKVESHIQP.LNQEDIYI   567 
Torafugu GHR1   PCSPEPAEGYGATTPQ-----AAATAERHQSPYILPDSPQTQVLAPVADYTVVQELDSQHSL   597 Gilthead GHR1   .ST.M.GS..QTIH..PVETKP.....NN...........S.FF...........V......   607 Torafugu GHR2   FPR.DMS.LFDSSHAS-------------T.HSHES.ATSNR---.APA....DGVSG.N..   529 Gilthead GHR2   LSIGDQS.PGLTGDLSP---------LPPA...HES.TTAVSP.P.APV....EGV.R.N..   548 Frog GHR        TTES---------------------LNIPEMNP-CFAEKASSYDM..S...S.HIIN.PQN.   574 Turtle GHR      TTES---------------------LTTTAENPGAAIVEASSSEM..P...SIHIIH.PQG.   584 Chicken GHR     TTES---------------------LTTTGINLGASMAETPSMEM..P...SIHIVH.PQG.   577 Mouse GHR       TTES---------------------LTTTAQMSETA.IAPDA-EMS.P...T.HTVQ.PRG.   618 Human GHR       TTES---------------------LTTAAGRPGTGEHVPGS-EM..P...SIHIVQ.PQG.   607 
Torafugu GHR1   LLNPPARHSPPPPVPQNPLKAPPAMPVGYVTPDLLGNLSR   637 Gilthead GHR1   .....P.Q....CL.HH.T..LA................P   647 Torafugu GHR2   ..ATNSTSGLQLII.KS-----VPTST..L......SITP   564 Gilthead GHR2   ..T.NSTPA.QLII.KT-----MPT.G..L......SITP   583 Frog GHR        V..-----TTVL.NKEFL------A.C..M...QVNKVMK   603 Turtle GHR      V..-----ATAL...DKE----FMLSC...ST.Q.NKILP   615 Chicken GHR     V..-----ATAL...EKE----FN.SC...ST.Q.NKIMP   608 Mouse GHR       I..-----ATAL.L.DKKN---FPSSC...ST.Q.NKIMQ   650 Human GHR       I..-----ATAL.L.DKE----FLSSC...ST.Q.NKIMP   638  
box 1 
box 2 
Fig. 2-2. The alignment of the deduced amino acid sequences of torafugu GHR1 and GHR2 with those of GHRs from 
other vertebrate animals. Amino acid residues identical to those of torafugu GHR1 are indicated with dots. Dashes denote 
gaps to optimize the alignment. Numbers on the right margin show those from the N-terminal methionine. Putative signal 
peptides are boxed with dotted-line. Potential N-glycosylation sites are underlined. Conserved cysteine residues in the 
extracellular doma n a d tyrosine residues in the intracellular domain are highlighted in dark. Ligand binding motifs are 
represented by an open box. The transmembrane domains is shaded. Conserved boxes 1 and 2 are underlined and 
described as so. he accession numbers of proteins in the NCBI database are shown in Tables 2 and 3 
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Torafugu GHR2   .T.....Q.VTSTYS.IMLS.K..E....EM..L.LL..V...NMDIEQ.QVTDLVKS.SR.   203 Gilthead GHR2   .T..T..E.L..TY..I.LS.K..Q....AM...TLQ..V...SAS.DL.H.V.PVTV.QRS   200 Frog GHR        ....V....LTRMRI.IQLS.........SS..ISL...VHIK.A.ESQ.TI.DKVQTKYLP   190 Turtle GHR      .......T.LTRIHA.IQ.R.D.......QK..ITL...L..K.V.E.K.RE..PMLT.VVP   190 Chicken GHR     .......T.QT.IHG.IQ.R.D...T...QK..ITL...L..K.V.E.K.KE..PRLS.VVP   187 Mouse GHR       .........LT.IRG.IQ.S.Q...N...LK..IIL......K.V.ESK.KVMGPIWL.YCP   224 Human GHR       .......V.LT.IHA.IQ.R..A.RN..IQK...VL...L..K.V.E.K.KMMDPILT.SVP   216 
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Torafugu GHR1   SILVLIVLVAVSQQQRLMMILLPPVPAPKIKGINPELLKKGELDDLNFILSSGGMGSLPSYA   331 Gilthead GHR1   G..I..L.IGI...P..................D.......K..E......G....G.ST..   339 Torafugu GHR2   CVVAILM...IL..EK..VL......G.R.R.VDSK.....K.RE.TS..G.P-----LDLR   313 Gilthead GHR2   CLVAILM..II...EK..F.......G...R..D.......K.RE.TS..GGP-----.NLR   310 Frog GHR        GM.LVFIFIL.FKKK..K..I.....V......D.D..QR.K..EV.S..ACH-----DH.K   304 Turtle GHR      GLI.VMF.ILF.KHR..K.LI............D.D.....K..EV.S..ANH-----D..K   307 Chicken GHR     GLA.TAI.ILL.K.P..K.LIF....V......D.D.....K..EV.S..A.H-----DN.K   306 Mouse GHR       GVA.MLFV.IF.K...IK.LI.....V......D.D...E.K.EEV.T..GIH-----DN.K   342 Human GHR       GLT.MLFVFLF.K...IK.LI.....V......D.D...E.K.EEV.T..AIH-----D..K   333 
Torafugu GHR1   PEFYRDEPWVEFIEVDVEEGDAGEKLNSRDSDTLKLLGLPLSVSHSVNTMGSN-TISIPHDD   392 Gilthead GHR1   .D..Q...........A.DA..A..EENQG...QR..DP.QP...HM..GCA.-AV.F.D..   400 Torafugu GHR2   S.L.NND......DL.I..----------TTSR..D.DPDCLMQP.LLSDCTPPIF.FRD..   365 Gilthead GHR2   ..L.NND......DL.I..----------Q..K.TD.DTDCLMHR.LSSNCTPVS.GFRD..   362 Frog GHR        QQL.N.D.......L.LDDT------------DE.NE.SDTDRLLGEEHRKNHNCLGVKD..   354 Turtle GHR      .QL.N.NS......L.IDDP------------DE.TE..DTDRLLGD.HCK.HNCLGVKD..   357 Chicken GHR     TQL.N.DL......L.IDDS------------DE.NRVSDTDRLL.DDHLK.HSCLGAKD..   356 Mouse GHR       .D..N.DS......L.ID.A.----------VDE.TE.SDTDRLL.NDHEK.AGILGAKD..   394 Human GHR       ...HS.DS......L.ID.P------------DE.TEESDTDRLL.SDHEK.HSNLGVKDG.   383 
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box 2 
Fig. 2-2. Continued. 
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Fig. 2-3. Comparison of the exon-intron structures of GHRs between torafugu and zebrafish. Exons are shown 
by boxes, whereas introns by solid lines. Exons encoding signal peptide, extracellular domain, transmembrane 
domain, and intracellular domain are represented with black, white, dark gray, and light gray boxes, respectively. 
Untranslated regions are indicated with dotted-line boxes. Dotted lines connect corresponding exons among all 
structures. Torafugu GHR1 and GHR2 exons and zebrafish counterparts are numbered from the exon including 
the start codon. First exons of torafugu GHR1 and GHR2, zebrafish ghra and ghrb include 9, 11, 16 and 10 bp of 
5’-UTR, respectively  
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Fig. 2-4. The relative mRNA levels of torafugu GHR1 and GHR2 in various tissues. The relative mRNA levels 
of GHR1 (□) and GHR2 (■) were calculated using those of the β-actin gene as the internal control. Bars 
represent means ± SE (n=4). Significant difference (p < 0.05) in the relative mRNA levels of GHR1 and GHR2 
among tissues examined is shown by asterisk (*) 
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Fig. 2-5. The relative mRNA levels of torafugu GHR1 and GHR2 in torafugu (1) liver and (b) muscle slices 
treated with hyperosmolar  PBS (white bars) and rtGH (5 ng/ml, dark bars). 
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Fig. 2-6. The relative mRNA levels of torafugu IGF-I in torafugu liver slices treated with hyperosmolar PBS 
(white bars) and different concentrations of rtGH at (a)  5 ng/ml and (b) 200 ng/ml (dark bars). 
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Chapter 3 
Comparison of TAG distribution among tissues and serum lipoproteins 
between torafugu and red seabream 
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General discussion 
 
 Fish species are widely distributed over the world oceans. Their habitats are diverse and they 
have adapted to the environment by modifying their survival strategies including swimming performance 
(Yamanoue et al., 2010). The fish species having high swimming activity, such as red seabream and 
Atlantic salmon, always use their trunk body to move, whereas the fish species lying on the bottom of the 
ocean, such as torafugu and flounder, mainly use their fins to generate thrust. These behavioral 
differences lead to the differences of the energy metabolism. The species-specific distribution pattern of 
lipid accumulation is thought to be one of the phenotype reflecting these differences. With the recent 
progresses in fish research, the mechanisms of lipid metabolism have been demonstrated by molecular 
biological approaches. However, most of these studies were performed in fatty fish species. To increase 
the knowledge of the molecular mechanisms of lipid metabolism with comparison to lean fish species will 
help us to understand the more basic aspects of it. 
 GH is known to regulate the growth efficiency in vertebrates. This valuable hormone also has 
the role of maintaining energy metabolism in living body with its lipolytic effect in fatty fish as well as in 
mammals (Sheridan, 1994). In lean fish, however, there is less study on GH function of its lipid 
metabolism regulation. Therefore, in this study, the molecular mechanisms of GH on lipid metabolism in 
torafugu, a typical lean fish species, were investigated. 
 Torafugu belongs to the family Tetraodontidae, which includes more than 120 species of 
pufferfish. The extremely low lipid ratio of muscle to liver has been observed in several pufferfish species 
such as torafugu (Ando et al., 1993), four species of Indian marine puffer fish (Ghosh et al., 2005), and 
obscure puffer Takifugu obscurus (Liu et al., 2013). In Chapter 3, the TAG contents in liver and muscle in 
torafugu showed similar distribution patterns with total lipid contents (Kaneko et al., 2013). Our 
preliminary data on TAG contents in purple puffer Takifugu porphyreus and green spotted pufferfish 
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Tetraodon nigroviridis also revealed that both pufferfish accumulated less than 0.5% of TAG content in 
muscle and approximately 30% in liver as well as torafugu. These results suggest that the low lipid ratio 
of muscle to liver reflects TAG distribution among tissues as a common feature of pufferfish. 
The present study indicated that torafugu modulate their lipid metabolism in part with the 
function of GH. In Chapter 1, rtGH showed the gene expression regulation at tissue-dependent manner, 
including lipid metabolism-related genes. Torafugu have two types of GHRs, GHR1 and GHR2, and the 
tissue distributions of their transcripts were unique to torafugu, namely, skeletal muscle had the highest 
gene expression level of GHR1. Actually, the preliminary data on tissue distributions of two types of 
GHRs in green spotted pufferfish also showed the similar expression patterns (data not shown), 
suggesting that this is conserved among pufferfish. Since rtGH repressed the gene expression of 
lipogenesis enzyme in muscle ex vivo, torafugu GH could strongly attenuate the lipogenesis in muscle 
under natural condition because of the high abundance of GHR1 in vivo as revealed in Chapter 2. 
Meanwhile, rtGH showed the gene regulations that possibly result in the NEFA reduction by inhibiting its 
uptake and de novo synthesis followed by oxidation in liver ex vivo. Besides, the higher concentration of 
rtGH stimulation induced the apolipoprotein gene expression, maybe involving the lipoprotein secretion. 
These results suggest that torafugu GH regulates the whole-body lipid balance in a concentration 
dependent manner (Fig. 4-1). 
Although the rtGH treatments at the concentrations used in the present study significantly 
changed the several lipid metabolism-related gene expressions in liver ex vivo, the expression of IGF-I 
did not show any change by rtGH stimulation irrespective of concentration and incubation time. In many 
fatty fish species, the GH treatment induces the hepatic gene expression of IGF-I at the comparative 
concentration with the present study (Pierce et al., 2004; Leung et al., 2008; Pedroso et al., 2009; Pierce et 
al., 2011; Reindl et al., 2011). Taking these reports into account, the results obtained in this study suggest 
that torafugu liver has low capacity to produce IGF-I in response to GH stimulation. Histologically, the 
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liver consists of different cell types, parenchymal and non-parenchymal cells. The IGF-I gene expression 
is observed only in parenchymal cells in mammal (Uchijima et al., 1995). Patients of non-alcoholic fatty 
liver, whose parenchymal cells in liver accumulate lipids at high levels, show the low levels of circulating 
IGF-I (Arturi et al., 2011), suggesting the low capacity of producing IGF-I in fatty liver. These features 
are similar to those observed in torafugu liver. In fish, both the IGF-I production and lipid droplets 
accumulation are observed in liver (Eppler et al., 2007; Akiyoshi and Inoue, 2004), but the detailed 
localizations have not been identified. Since torafugu liver showed the high TAG content and mammalian 
adipose tissue-like response to rtGH stimulation (Oscarsson et al., 1996; Nam and Marcus, 2000; 
Louveau and Gondret, 2004; Hogan et al., 2005), there would be histological differences in torafugu liver 
compared to mammals. Further analysis for detailed identification of the localization of lipid droplets will 
assess this hypothesis. 
In Chapter 3, the TAG content of torafugu serum was revealed to be comparative to that of 
red seabream. The TAG distribution among lipoproteins analyzed by HPLC showed the higher TAG 
content in torafugu TAG-rich lipoprotein fraction than that in red seabream. There may be two reasons 
causing this difference. One is the weak incorporation of TAG into torafugu muscle as discussed in 
Chapter 3. The TAG in TAG-rich lipoproteins is hydrolyzed by LPL function localized on the surface of 
endothelial cells of tissues. The previous study showed that the LPL mediates the selective uptake of 
TAG-rich lipoprotein through receptor-mediated endocytosis (Merkel et al., 1998). Although the VLDL 
receptor distribution in torafugu has not been confirmed yet, the extremely low TAG content in its muscle 
is possibly caused by the low level of LPL1 gene expression (Kaneko et al., 2013). To confirm this, the 
comparison of the enzymatic activity of LPL in muscle between torafugu and red seabream should be 
performed. The other reason for the high TAG content in TAG-rich lipoprotein fraction in torafugu might 
be an enhanced release of TAG-rich lipoprotein from torafugu liver. In the present study, torafugu rtGH 
stimulated the apolipoprotein gene expression in liver slices. The liver had low capacity to express the 
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IGF-I gene in response to GH. Previous studies showed that IGF-I has a role as a negative feedback 
regulator for GH secretion in fish pituitary as in mammals (Perez-Sanchez et al., 1992; Fruchtman et al., 
2000). Therefore, in torafugu, the negative feedback by IGF-I could be attenuated and it results in the 
high concentration of circulating GH, enhancing the apolipoprotein expression in liver. This second 
hypothesis, however, leads a contradiction with the lipolytic effects of rtGH revealed in this study. Since 
torafugu accumulates high amounts of TAG in liver, the basal lipogenesis activity should be high. To get 
rid of this, some previous studies have to be cited. Liver-specific IGF-I deletion leads the elevated both 
basal levels of GH and insulin, an anabolic peptide hormone produced by pancreas (Sjögren et al., 2002). 
Insulin enhances lipogenesis activity and increases the TAG content of isolated hepatocytes in catfish 
Pelteobagrus fulvidraco (Zhuo et al., 2014). In this study, microarray analysis indicated that the rtGH 
stimulation does not change the expression level of insulin receptor in torafugu liver (data not shown). 
These information implies the possibility that the low IGF-I production in torafugu liver causes the 
elevation of both GH and insulin, the former regulates the lipoprotein secretion and the latter keeps the 
basal lipogenesis activity. Taken together, the TAG content in torafugu serum, which is comparative to 
that in red seabream, is possibly kept by the attenuated uptake into muscle and/or the enhanced 
lipoprotein secretion from liver (Fig. 4-2). To assess these hypotheses, it is essential to confirm the 
concentration of GH and insulin in torafugu circulation. The VLDL releasing capacity of torafugu and red 
seabream also should be compared in vivo. 
The present study strongly indicates that torafugu has unique GH/GHR signaling compared to 
the fatty fish species. Whether this is a common feature in lean fish or not is unclear because of the less 
study on GH and GHR characteristics of lean fish species. Exceptionally, the studies of GH/GHR 
signaling in fine flounder Paralichthys adspersus, one of the typical lean fish, showed that the serum 
concentration of GH is not exceeding 10 ng/ml under normal feeding condition in several fish species 
belonging to fatty fish (Kajimura et al., 2004; Pierce et al., 2005; Gabillard et al., 2006; Shimizu et al., 
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2009). On the other hand, fine flounder contains the higher basal level of circulating GH (100 to 170 
ng/ml) together with low IGF-I level (Fuentes et al., 2012a and b). The tissue distribution of GHR in this 
species is determined only for GHR1 by semi-quantitative way (Fuentes et al., 2008). Therefore it is 
difficult to compare the tissue distribution pattern of GHR between fine flounder and torafugu. 
Interestingly, Fuentes et al. (2012a) revealed by Western blot analysis that fine flounder contains high 
amount of truncated GHR, a short form of GHR lacking the intracellular domain, in muscle. It is known 
in mammalian species that the GHR gene produces not only the full length GHR but also the short forms 
of GHR by posttranscriptional or posttranslational modifications, such as GH binding protein (GHBP) 
and truncated GHR (Dastot et al., 1998). The GHBP is a soluble form of GHR circulating in blood stream 
to regulate the half-life of GH (Veldhuis et al., 1993). The truncated GHR is a short membrane-anchored 
form of GHR lacking the intracellular domain that has the dominant-negative function for transmitting 
GH signaling (Ahmed et al., 2011). Fuentes et al. (2012a) confirmed that the abundance of truncated 
GHR is almost 4-fold higher than full length GHR, possibly resulting in the local GH resistance. GHBP 
and truncated GHR are identified in several fish species (Marchant et al., 1999; Perez-Sanchez et al., 
2002; Fuentes et al., 2013; Einarsdottir et al., 2014) but not yet in torafugu. In this study, because the 
tissue distributions of GHR transcripts in torafugu were analyzed by using the gene-specific primers 
designed based on the extracellular domain sequences, the ratio of full length and truncated GHRs is 
unclear. Since this ratio will affect the actual GH signaling of each tissue, further investigations for the 
ratio of full length and truncated GHRs are necessary for understanding the GH/GHR signaling in 
torafugu. 
In conclusion, this study revealed that the extremely low lipid ratio of muscle to liver in 
torafugu reflects the difference of TAG distribution, the neural lipids used as energy sources, although the 
TAG transport capacity by lipoproteins is higher than that of red seabream, which contains significantly 
higher TAG level in its muscle than torafugu. The cDNA cloning of two types of torafugu GHR and their 
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tissue distribution analyses confirmed that both torafugu GHR1 and GHR2 transcripts were ubiquitously 
expressed in various tissues. Especially, the highest mRNA level of GHR1 was observed in its muscle. 
The rtGH was demonstrated to exert the suppression effect of lipogenesis in muscle ex vivo. These results 
indicate that GH/GHR signaling is involved in the low TAG contents in torafugu muscle. Meanwhile, the 
rtGH also showed the lipolytic effects in liver ex vivo. A high concentration of rtGH enhanced the 
apolipoprotein expression, possibly related to the TAG-rich lipoprotein secretion. The whole body lipid 
balances in torafugu would be regulated in a GH-dependent manner. 
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